5,460
Views
6
CrossRef citations to date
0
Altmetric
Dermatology

Economic evaluation of a JAK inhibitor compared to a monoclonal antibody for treatment of moderate-to-severe atopic dermatitis from a UK perspective

, ORCID Icon & ORCID Icon
Pages 491-502 | Received 07 Jan 2022, Accepted 25 Mar 2022, Published online: 09 Apr 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.